Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet cyclic AMP in essential hypertension.

M M Mazeaud1, K H Le Quan Sang, M A Devynck

  • 1INSERM U7, Department of Pharmacology, Hôpital Necker, Paris, France.

Journal of Hypertension
|June 1, 1989
PubMed
Summary

Essential hypertension is linked to lower platelet cyclic AMP (cAMP) levels. This reduction in cAMP may contribute to increased platelet sensitivity in hypertensive individuals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunopathological manifestations in Kabuki syndrome: a registry study of 177 individuals.

Genetics in medicine : official journal of the American College of Medical Genetics·2019
Same author

Perinatal and infantile hypophosphatasia: clinical features and treatment.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2018
Same author

Ketone Bodies as a Possible Adjuvant to Ketogenic Diet in PDHc Deficiency but Not in GLUT1 Deficiency.

JIMD reports·2017
Same author

Effects of adrenaline on ionic equilibria in red blood cells of rainbow trout (Salmo gairdneri).

Fish physiology and biochemistry·2013
Same author

First fixed drug eruption due to teicoplanin with a peri-oral distribution.

Journal of the European Academy of Dermatology and Venereology : JEADV·2009
Same author

[Absence of nephro-protective effect of acetylcysteine in patients with chronic renal failure investigated by coronary angiography].

Archives des maladies du coeur et des vaisseaux·2004

Area of Science:

  • Biochemistry
  • Cardiovascular Physiology
  • Platelet Biology

Background:

  • Essential hypertension is associated with platelet metabolic abnormalities, including heightened sensitivity to aggregating agents.
  • Platelet function is regulated by opposing calcium (Ca2+) and cyclic adenosine monophosphate (cAMP) dependent pathways.

Purpose of the Study:

  • To investigate cyclic adenosine monophosphate (cAMP) levels in platelets of individuals with essential hypertension compared to normotensive subjects.
  • To determine the role of phosphodiesterase inhibition and calcium influx in altered cAMP metabolism in hypertension.

Main Methods:

  • Radioimmunoassay was used to measure platelet cAMP content in basal and prostaglandin E1 (PGE1)-stimulated states.
  • Experiments were conducted with and without Ro 15-2041 (a phosphodiesterase inhibitor) and varying external Ca2+ concentrations.

Main Results:

  • Platelets from hypertensive subjects exhibited lower basal and PGE1-stimulated cAMP levels compared to normotensive subjects.
  • Inhibition of phosphodiesterase by Ro 15-2041 resulted in similar cAMP increases in both groups.
  • Reduced external Ca2+ lowered cAMP in both groups, but the difference between hypertensive and normotensive subjects persisted.

Conclusions:

  • The observed reduction in platelet cAMP in essential hypertension is not due to phosphodiesterase alterations or altered calcium influx.
  • Lowered platelet cAMP content may contribute to the hyperreactivity of platelets seen in essential hypertension.

Related Experiment Videos